The effects of anti-SARS-CoV-2 monoclonal antibodies on pregnant and postpartum women - News-Medical.Net

Researchers examine the safety and efficacy of mAbs in pregnant and postpartum women with COVID-19.

Pregnancy is recognized to be a high-risk condition for complications associated with infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As a result, many healthcare provi… [+5854 chars]

full article...